Study Demonstrates AspenBio Pharma’s AppyScore Multi-Marker Blood Test Highly Predictive for Absence of Acute Appendicitis in Children with Abdominal Pain
 
Clinical Data to be Presented at Annual Meeting of the
Society for Academic Emergency Medicine 

Published annually by the CBSA, this magazine is the "gold standard" for the bioscience industry and is the only marketing collateral used by the CBSA and economic development agencies to promote the bioscience sector in Colorado.
  
Ad rates starting at $650! 

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced a collaboration with Kadmon Corporation, LLC, to explore the utility of Biodesix’ VeriStrat® test in a Phase 3 non-small cell lung cancer (NSCLC) study of Kadmon’s KD019, a reversible tyrosine kinase inhibitor (TKI) targeting EGFR, HER2, VEGFR2 & 3, and SRC.  

Working to create a device that is easy-to-operate and can be used in the doctor’s office or remotely in the field Key goal is to enable device to be quickly adapted to diagnose new strains of the flu and other emerging
infectious diseases Small biotech business in Boulder, Colorado partnering with GE to increase its workforce 

Boulder County Business Report 

RMC Pharmaceutical Solutions Relocates for third time in eight years
Expanding company provides additional space for research 

Occupy Washington: Med-tech delegations from 18 states set to take Capitol Hill
 

"Venture capitalists invested $66.1 million in six Colorado companies working in the fields of biofuel, medical devices and biopharma last year, according to a report released Tuesday by OnBioVC...  

WESTMINSTER, Colo., USA (February 22, 2012) – Surefire Medical, Inc., a Colorado-based medical device company, announced today that Robert M. Holburn, Jr. will join the company as Chief Financial Officer. 

By Beth Potter